MATERNUS-Kliniken AG

As of June 30, 2016, MATERNUS-Kliniken AG has 20.97M shares outstanding.

As of June 30, 2016, MATERNUS-Kliniken AG maintains a current ratio of 0.50, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -2,123.40, indicating conservative leverage, while an interest coverage ratio of 2.44 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2016. Return on invested capital (ROIC) comes in at 8.15 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.88, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.15, useful for judging operating efficiency across full business cycles. Inventory turnover of 52.84 indicates how many times MATERNUS-Kliniken AG sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2016, MATERNUS-Kliniken AG recorded 504,000.00 in income tax expense. That works out to an effective tax rate of 18.50, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.73M, leaving 2.22M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 20, 2026, MATERNUS-Kliniken AG's stock has declined approximately 19.05% over the past 52 weeks.

Over the twelve months ended June 30, 2016, MATERNUS-Kliniken AG generated 123.88M in revenue and converted that into 2.22M in net income, yielding earnings per share of 0.11. EBITDA reached 13.57M, while operating income came in at 8.28M.

As of June 30, 2016, MATERNUS-Kliniken AG holds 6.66M in cash and equivalents against 88.19M in total debt, resulting in a net debt position of 4.94M. Total book value stands at -4.15M, with working capital of -14.99M providing operational flexibility.

These figures cover the twelve months ended June 30, 2016.

Over the twelve months ended June 30, 2016, MATERNUS-Kliniken AG posted a gross margin of 82.79, reflecting its pricing power and cost economics. The operating margin of 6.68 and net profit margin of 1.79 provide insight into operational efficiency.

MATERNUS-Kliniken AG's most recent stock split took place on March 13, 1997.